FDA, USP Should Set Generic Biologics Standards, Sen. Hatch Proposes
Executive Summary
Generic biologics should be a priority issue for the next FDA commissioner, Sen. Orrin Hatch (R-Utah) says
You may also be interested in...
BIO Likes EU Model For Follow-On Biologics; Standards Are “Appropriate”
The European Union approach to follow-on biologic products sets an "appropriate" standard, the Biotechnology Industry Organization said
BIO Likes EU Model For Follow-On Biologics; Standards Are “Appropriate”
The European Union approach to follow-on biologic products sets an "appropriate" standard, the Biotechnology Industry Organization said
Senate Change Puts Hatch, Gregg, Grassley In Line For Key Rx Committees
The transfer of control in the Senate puts Sen. Orrin Hatch (R-Utah) in position to have greater influence in guiding generic drug reform legislation